Literature DB >> 26273081

Low FODMAP diet.

Cian Hackett, Michael R Kolber1.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 26273081      PMCID: PMC4541433     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  16 in total

Review 1.  An evidence-based position statement on the management of irritable bowel syndrome.

Authors:  Lawrence J Brandt; William D Chey; Amy E Foxx-Orenstein; Lawrence R Schiller; Philip S Schoenfeld; Brennan M Spiegel; Nicholas J Talley; Eamonn M M Quigley
Journal:  Am J Gastroenterol       Date:  2009-01       Impact factor: 10.864

2.  The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress.

Authors:  C Y Francis; J Morris; P J Whorwell
Journal:  Aliment Pharmacol Ther       Date:  1997-04       Impact factor: 8.171

3.  Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome.

Authors:  Derrick K Ong; Shaylyn B Mitchell; Jacqueline S Barrett; Sue J Shepherd; Peter M Irving; Jessica R Biesiekierski; Stuart Smith; Peter R Gibson; Jane G Muir
Journal:  J Gastroenterol Hepatol       Date:  2010-08       Impact factor: 4.029

Review 4.  Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis.

Authors:  Abigail Marsh; Enid M Eslick; Guy D Eslick
Journal:  Eur J Nutr       Date:  2015-05-17       Impact factor: 5.614

5.  Meta-analysis: factors affecting placebo response rate in the irritable bowel syndrome.

Authors:  A C Ford; P Moayyedi
Journal:  Aliment Pharmacol Ther       Date:  2010-04-16       Impact factor: 8.171

6.  Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence.

Authors:  Susan J Shepherd; Francis C Parker; Jane G Muir; Peter R Gibson
Journal:  Clin Gastroenterol Hepatol       Date:  2008-05-05       Impact factor: 11.382

7.  Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial.

Authors:  W Atkinson; T A Sheldon; N Shaath; P J Whorwell
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

Review 8.  Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis.

Authors:  Alexander C Ford; William D Chey; Nicholas J Talley; Ashish Malhotra; Brennan M R Spiegel; Paul Moayyedi
Journal:  Arch Intern Med       Date:  2009-04-13

9.  Placebos without deception: a randomized controlled trial in irritable bowel syndrome.

Authors:  Ted J Kaptchuk; Elizabeth Friedlander; John M Kelley; M Norma Sanchez; Efi Kokkotou; Joyce P Singer; Magda Kowalczykowski; Franklin G Miller; Irving Kirsch; Anthony J Lembo
Journal:  PLoS One       Date:  2010-12-22       Impact factor: 3.240

10.  Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial.

Authors:  C J Bijkerk; N J de Wit; J W M Muris; P J Whorwell; J A Knottnerus; A W Hoes
Journal:  BMJ       Date:  2009-08-27
View more
  3 in total

1. 

Authors:  Paul Fritsch; Michael R Kolber; Christina Korownyk
Journal:  Can Fam Physician       Date:  2020-04       Impact factor: 3.275

2.  Antidepressants for irritable bowel syndrome.

Authors:  Paul Fritsch; Michael R Kolber; Christina Korownyk
Journal:  Can Fam Physician       Date:  2020-04       Impact factor: 3.275

Review 3.  Top studies relevant to primary care practice.

Authors:  Danielle Perry; Michael R Kolber; Christina Korownyk; Adrienne J Lindblad; Jamil Ramji; Joey Ton; G Michael Allan
Journal:  Can Fam Physician       Date:  2018-04       Impact factor: 3.275

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.